AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Disc Medicine, Inc. Director's Dealing 2021

Nov 16, 2021

31589_dirs_2021-11-16_b8e85273-43f6-4d8f-9151-cdde3e1da2a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemini Therapeutics, Inc. /DE (GMTX)
CIK: 0001816736
Period of Report: 2021-11-15

Reporting Person: GEMAYEL GEORGES (Director, See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-15	Stock Option (Right to Buy)	$3.58	A	23514	Acquired	2031-11-14	Common Stock (23514)	Direct
2021-11-15	Stock Option (Right to Buy)	$3.58	A	17245	Acquired	2031-11-14	Common Stock (17245)	Direct

Footnotes

F1: 100% of the option shall vest on August 5, 2022 so long as the Optionee continues to have a Service Relationship with the Company on such date.

F2: 100% of the option shall vest on the earlier of (a) the one-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date.